SelleckChem - Inhibitor expert

Selleck Chemicals is one of the world leading suppliers of small molecules, inhibitors and inhibitor libraries, with a portfolio of more than 8,000 products. These are directed at diverse signaling pathways, such as MAPK, PI3K/Akt or apoptosis. Compound libraries for high-throughput screening and high-content screening are also available by SelleckChem.

SelleckChem is committed to meeting and exceeding customer requirements. They realize this goal by establishing and maintaining outstanding quality and quality assurance standards. Quality manual

Product offering

  • Small molecules
  • Kinase inhibitors
  • Pathway inhibitors
  • Protease inhibitors
  • Kinase inhibitor libraries
  • FDA-approved drug libraries
  • Natural compound libraries
  • Cambridge and Pfizer based compound libraries

A selection of some of the available screening libraries can be found below.

Screening libraries

Bioactive Compound LibraryL1700-100UL/WELL100 μl/well 
Kinase Inhibitor LibraryL1200-100UL/WELL100 μl/well 
Inhibitor LibraryL1100-100UL/WELL100 μl/well 
Epigenetics Compound LibraryL1900-100UL/WELL100 μl/well 
Natural Product LibraryL1400-100UL/WELL100 μl/well
Anti-cancer Compound LibraryL3000-100UL/WELL100 μl/well
PI3K/Akt Inhibitor LibraryL2800-100UL/WELL100 μl/well
Protease Inhibitor LibraryL2500-100UL/WELL100 μl/well

FDA-approved drug library

  • 1163 FDA-approved drugs
  • A unique collection of 1'163 FDA approved drugs for high throughput screening (HTS) and high content screening (HCS)


  • NMR and HPLC validated to ensure high purity
  • All compounds have been approved by FDA
  • Related to oncology, cardiology, anti-inflammatory, immunology, neuropsychiatry, analgesia etc.
  • Structurally diverse, medicinally active, and cell permeable
  • Rich documentation with structure, IC50, and customer reviews
  • Two-dimensional bar code available in SDF and XLSF files
FDA-approved Drug LibraryL1300-100UL/WELL100 μl/well
FDA-approved Drug Library L1300-250UL/WELL250 μl/well